Bebb, D.G.; Banerji, S.; Blais, N.; Desmeules, P.; Gill, S.; Grin, A.; Feilotter, H.; Hansen, A.R.; Hyrcza, M.; Krzyzanowska, M.;
et al. Canadian Consensus for Biomarker Testing and Treatment of TRK Fusion Cancer in Adults. Curr. Oncol. 2021, 28, 523-548.
https://doi.org/10.3390/curroncol28010053
AMA Style
Bebb DG, Banerji S, Blais N, Desmeules P, Gill S, Grin A, Feilotter H, Hansen AR, Hyrcza M, Krzyzanowska M,
et al. Canadian Consensus for Biomarker Testing and Treatment of TRK Fusion Cancer in Adults. Current Oncology. 2021; 28(1):523-548.
https://doi.org/10.3390/curroncol28010053
Chicago/Turabian Style
Bebb, D. Gwyn, Shantanu Banerji, Normand Blais, Patrice Desmeules, Sharlene Gill, Andrea Grin, Harriet Feilotter, Aaron R. Hansen, Martin Hyrcza, Monika Krzyzanowska,
and et al. 2021. "Canadian Consensus for Biomarker Testing and Treatment of TRK Fusion Cancer in Adults" Current Oncology 28, no. 1: 523-548.
https://doi.org/10.3390/curroncol28010053
APA Style
Bebb, D. G., Banerji, S., Blais, N., Desmeules, P., Gill, S., Grin, A., Feilotter, H., Hansen, A. R., Hyrcza, M., Krzyzanowska, M., Melosky, B., Noujaim, J., Purgina, B., Ruether, D., Simmons, C. E., Soulieres, D., Torlakovic, E. E., & Tsao, M. -S.
(2021). Canadian Consensus for Biomarker Testing and Treatment of TRK Fusion Cancer in Adults. Current Oncology, 28(1), 523-548.
https://doi.org/10.3390/curroncol28010053